Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.
We investigated the pharmacokinetics of zidovudine, zalcitabine, and saquinavir in AIDS Clinical Trial Group protocol 229. Patients received either saquinavir, zalcitabine, or a combination of both, together with zidovudine three times a day. Approximately 100 patients were enrolled in each treatmen...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1997
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164140/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9371345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.11.2428 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
